Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis.
Huibo WangNana ZhangQi SunZiqi ZhaoHui PangXiatian HuangRuifeng ZhangWenli KangMing ShanPublished in: Journal of cancer research and clinical oncology (2024)
In stage II-III triple TNBC patients, the NACT regimen combining taxanes and carboplatin yields higher rates of pCR and significant improvements in EFS and OS as compared to the regimen combining anthracyclines and taxanes.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- locally advanced
- ejection fraction
- phase ii study
- lymph node
- newly diagnosed
- chronic kidney disease
- sentinel lymph node
- peritoneal dialysis
- squamous cell carcinoma
- randomized controlled trial
- radiation therapy
- early stage
- clinical trial
- patient reported
- study protocol